These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 9499384

  • 21. Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T15.
    Cheng L, Tachibana K, Iwasaki H, Kameyama A, Zhang Y, Kubota T, Hiruma T, Tachibana K, Kudo T, Guo JM, Narimatsu H.
    FEBS Lett; 2004 May 21; 566(1-3):17-24. PubMed ID: 15147861
    [Abstract] [Full Text] [Related]

  • 22. Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth.
    Taniuchi K, Cerny RL, Tanouchi A, Kohno K, Kotani N, Honke K, Saibara T, Hollingsworth MA.
    Oncogene; 2011 Dec 08; 30(49):4843-54. PubMed ID: 21625220
    [Abstract] [Full Text] [Related]

  • 23. Studies of acceptor site specificities for three members of UDP-GalNAc:N-acetylgalactosaminyltransferases by using a synthetic peptide mimicking the tandem repeat of MUC5AC.
    Tetaert D, Richet C, Gagnon J, Boersma A, Degand P.
    Carbohydr Res; 2001 Jul 03; 333(2):165-71. PubMed ID: 11448678
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. cDNA cloning and expression of a novel human UDP-N-acetyl-alpha-D-galactosamine. Polypeptide N-acetylgalactosaminyltransferase, GalNAc-t3.
    Bennett EP, Hassan H, Clausen H.
    J Biol Chem; 1996 Jul 19; 271(29):17006-12. PubMed ID: 8663203
    [Abstract] [Full Text] [Related]

  • 26. Structural basis of carbohydrate transfer activity by human UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase (pp-GalNAc-T10).
    Kubota T, Shiba T, Sugioka S, Furukawa S, Sawaki H, Kato R, Wakatsuki S, Narimatsu H.
    J Mol Biol; 2006 Jun 09; 359(3):708-27. PubMed ID: 16650853
    [Abstract] [Full Text] [Related]

  • 27. A novel human UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for partial GalNAc-glycosylated acceptor substrates.
    Bennett EP, Hassan H, Hollingsworth MA, Clausen H.
    FEBS Lett; 1999 Oct 29; 460(2):226-30. PubMed ID: 10544240
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Characterization of the UDP-N-acetylgalactosamine binding domain of bovine polypeptide alphaN-acetylgalactosaminyltransferase T1.
    Duclos S, Da Silva P, Vovelle F, Piller F, Piller V.
    Protein Eng Des Sel; 2004 Aug 29; 17(8):635-46. PubMed ID: 15377782
    [Abstract] [Full Text] [Related]

  • 30. Dynamic epigenetic regulation of initial O-glycosylation by UDP-N-Acetylgalactosamine:Peptide N-acetylgalactosaminyltransferases. site-specific glycosylation of MUC1 repeat peptide influences the substrate qualities at adjacent or distant Ser/Thr positions.
    Hanisch FG, Müller S, Hassan H, Clausen H, Zachara N, Gooley AA, Paulsen H, Alving K, Peter-Katalinic J.
    J Biol Chem; 1999 Apr 09; 274(15):9946-54. PubMed ID: 10187769
    [Abstract] [Full Text] [Related]

  • 31. The specificity of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase as inferred from a database of in vivo substrates and from the in vitro glycosylation of proteins and peptides.
    Elhammer AP, Poorman RA, Brown E, Maggiora LL, Hoogerheide JG, Kézdy FJ.
    J Biol Chem; 1993 May 15; 268(14):10029-38. PubMed ID: 8486674
    [Abstract] [Full Text] [Related]

  • 32. UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyl-transferase from the snail Biomphalaria glabrata - substrate specificity and preference of glycosylation sites.
    Taus C, Windwarder M, Altmann F, Grabherr R, Staudacher E.
    Glycoconj J; 2014 Dec 15; 31(9):661-70. PubMed ID: 25338825
    [Abstract] [Full Text] [Related]

  • 33. The influence of flanking sequence on the O-glycosylation of threonine in vitro.
    O'Connell BC, Hagen FK, Tabak LA.
    J Biol Chem; 1992 Dec 15; 267(35):25010-8. PubMed ID: 1460004
    [Abstract] [Full Text] [Related]

  • 34. Mucin-type O-glycosylation in helminth parasites from major taxonomic groups: evidence for widespread distribution of the Tn antigen (GalNAc-Ser/Thr) and identification of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
    Casaravilla C, Freire T, Malgor R, Medeiros A, Osinaga E, Carmona C.
    J Parasitol; 2003 Aug 15; 89(4):709-14. PubMed ID: 14533679
    [Abstract] [Full Text] [Related]

  • 35. Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus.
    Röttger S, White J, Wandall HH, Olivo JC, Stark A, Bennett EP, Whitehouse C, Berger EG, Clausen H, Nilsson T.
    J Cell Sci; 1998 Jan 15; 111 ( Pt 1)():45-60. PubMed ID: 9394011
    [Abstract] [Full Text] [Related]

  • 36. The participation of ribosome-UDP-GalNAc complex in the initiation of protein glycosylation in vitro.
    Paszkiewicz-Gadek A, Porowska H, Gindzieński A.
    Acta Biochim Pol; 2000 Jan 15; 47(2):421-6. PubMed ID: 11051206
    [Abstract] [Full Text] [Related]

  • 37. Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2.
    Brockhausen I, Dowler T, Paulsen H.
    Biochim Biophys Acta; 2009 Oct 15; 1790(10):1244-57. PubMed ID: 19524017
    [Abstract] [Full Text] [Related]

  • 38. Purification, cloning, and expression of a bovine UDP-GalNAc: polypeptide N-acetyl-galactosaminyltransferase.
    Hagen FK, Van Wuyckhuyse B, Tabak LA.
    J Biol Chem; 1993 Sep 05; 268(25):18960-5. PubMed ID: 8360184
    [Abstract] [Full Text] [Related]

  • 39. Function of the lectin domain of polypeptide N-acetylgalactosaminyltransferase 1.
    Tenno M, Kézdy FJ, Elhammer AP, Kurosaka A.
    Biochem Biophys Res Commun; 2002 Nov 15; 298(5):755-9. PubMed ID: 12419318
    [Abstract] [Full Text] [Related]

  • 40. Human Immunodeficiency Virus and Simian Immunodeficiency Virus Maintain High Levels of Infectivity in the Complete Absence of Mucin-Type O-Glycosylation.
    Termini JM, Church ES, Silver ZA, Haslam SM, Dell A, Desrosiers RC.
    J Virol; 2017 Oct 01; 91(19):. PubMed ID: 28747495
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.